FDA Suspends Chikungunya Vaccine Over Safety Concerns
The U.S. Food and Drug Administration (FDA) announced on Aug. 22, 2025 that it has suspended the license for French drugmaker Valneva’s chikungunya vaccine, warning that its continued use “poses a danger to public health” following a risk–benefit analysis conducted by the agency’s Center for Biologics Evaluation and Research (CBER). The decision came after reports […]
FDA, CDC Halt Use of Chikungunya Vaccine in Adults 60+ After Two Deaths Reported
On May 9, 2025, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) recommended a temporary pause in the use of Ixchiq, a live virus vaccine designed to prevent chikungunya virus infection, in adults aged 60 years and older. The recommendation follows reports of serious post-marketing adverse […]
Is a Bill Requiring Your Children to Get Every CDC Recommended Vaccination Coming to Your State?
As vaccine-related bills are being introduced into state legislatures this month, a bill (HB1090) has been proposed in the Virginia legislature to require school children to receive every dose of all current and future vaccines added to the recommended childhood vaccine schedule by the Advisory Committee on Immunization Practices (ACIP) appointed by the U.S. Centers […]